VuEssence: Funding, Investors & Team (Sep 2026)
VuEssence is a startup company that is dedicated to developing molecular diagnostic solutions to help with the detection, treatment, and comprehension of diseases. The company uses cutting-edge technologies to analyze the human genome and transcription. Its devices provide support for physicians in managing patients with complex medical conditions. VuEssence was established in 2010 by Maha Sallam and is based in Odessa, Florida.
VuEssence has raised $50k across 1 funding round on record, the most recent an undisclosed round of $50k announced in May 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
VuEssence Company Profile and Key Stats
Latest funding round on record: May 2025.
VuEssence Funding Rounds
VuEssence Founders and Leadership Team
Contact details for the VuEssence team: 1 of 1 has an email address on file.
Start 14-day free trial →VuEssence Funding Compared to Other Biotechnology Startups
VuEssence's latest round of $50k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VuEssence in Biotechnology and Odessa
Companies Similar to VuEssence
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
VuEssence Funding FAQs
What does VuEssence do?
VuEssence is a startup company that is dedicated to developing molecular diagnostic solutions to help with the detection, treatment, and comprehension of diseases. The company uses cutting-edge technologies to analyze the human genome and transcription. Its devices provide support for physicians in managing patients with complex medical conditions. VuEssence was established in 2010 by Maha Sallam and is based in Odessa, Florida.
How much funding has VuEssence raised?
VuEssence has raised $50k across 1 round on record. The most recent is an undisclosed round of $50k announced in May 2025.
When did VuEssence last raise funding?
VuEssence's most recent funding round on record is an undisclosed round of $50k, announced in May 2025.
Who founded VuEssence?
FundedIQ lists Maha Sallam (Founder) at VuEssence.
Where is VuEssence headquartered?
VuEssence is based in Odessa, Florida, United States.
How many employees does VuEssence have?
VuEssence is in the 11-50 employee band.
How does VuEssence's funding compare to other Biotechnology startups?
VuEssence's latest round of $50k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's VuEssence Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VuEssence is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.